Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
Prostate Cancer
Drug:
goserelin acetate
(
GnRH agonist
)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A1 - Approval
New
Source:
FDA
Excerpt:
ZOLADEX is a Gonadotropin Releasing Hormone (GnRH) agonist indicated for:...Palliative treatment of advanced carcinoma of the prostate...
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
NCCN
Excerpt:
Prostate cancer: PRINCIPLES OF ANDROGEN DEPRIVATION THERAPY...ADT for Regional (N1,M0) Disease…Options for ADT are: LHRH agonist alone...Goserelin, histrelin, leuprolide, or triptorelin
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login